论文信息 - Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) - 字舞流文

Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)

M. Addo | A. Bergmann | A. Nierhaus | S. Kluge | G. Marx | M. Karakas | M. Lütgehetmann | K. Roedl | T. Simon | D. Jarczak | M. Becker | Frauke Hein | Jens Zimmermann